Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in glioma

Abstract The immunosuppressive tumor microenvironment of glioblastoma limits the effectiveness of most immunotherapies. Transforming growth factor (TGF)-β signaling drives tumor progression and prevents effective T cell activity. Notably, both regulatory T cells (Tregs) and effector T cells within g...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniela Lorizio, Manuela Silginer, Julia Friesen, Alan L. Epstein, Michael Weller, Patrick Roth
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-025-04098-w
Tags: Add Tag
No Tags, Be the first to tag this record!